Pericardial disease in patients treated with immune checkpoint inhibitors.

J Immunother Cancer · 2021 · PMC8215235 · PMID 34145031

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significancep=0.06so close (0.05 < p ≤ 0.1)

A history of lung cancer significantly increased the risk of developing pericardial disease (HR 5.46, 95% CI 2.96 to 10.10, p<0.001) but the associations between pericardial disease with baseline corticosteroid use and history of cardiovascular events did not reach statistical significance (p=0.06 and p=0.06, respectively, table 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.